— Know what they know.
Not Investment Advice

CBDY OTC

Target Group Inc.
1W: -12.5% 1M: -30.0% 3M: -41.7% YTD: -53.3% 1Y: -58.8% 3Y: -89.5% 5Y: -96.1%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 44 · $431918 mcap · 555M float · 0.042% daily turnover · Short 55% of daily vol

Supply Chain Overview

4 relationships
4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-05-09
Earliest Filing
2022-05-09
Latest Filing
partner: 4

Counterparties (Filed by CBDY)

4 relationships

Companies named in CBDY's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
CanaryRx Inc. — partner Second-tier subsidiary of Target Group Inc. involved in a Joint Venture Operations Agreement and Payout Agreement. 2022-05-09 View
9258159 Canada Inc. — partner Entity referred to as 'Thrive' that entered into a Joint Venture Operations Agreement and Payout Agreement. 2022-05-09 View
2755757 Ontario Inc. — partner Entity referred to as 'JVCo' that entered into a Joint Venture Operations Agreement and Payout Agreement. 2022-05-09 View
Terrafarma Inc. — partner Parent company of Thrive that entered into a Payout Agreement to discharge indebtedness to CanaryRx. 2022-05-09 View
Recent 8-K Filings (12)
Filing Date Description Type SEC
2025-08-18 Creation of Direct Financial Obligation View
2024-08-26 Creation of Direct Financial Obligation View
2023-11-13 Creation of Direct Financial Obligation View
2023-08-04 Creation of Direct Financial Obligation View
2023-03-27 Departure/Election of Directors; Appointment of Officers View
2023-02-22 Creation of Direct Financial Obligation View
2022-10-21 Creation of Direct Financial Obligation View
2022-05-09 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2022-02-18 Creation of Direct Financial Obligation; Financial Statements and Exhibits View
2021-06-24 Unregistered Sales of Equity Securities View
2021-06-22 Creation of Direct Financial Obligation View
2021-06-15 Regulation FD Disclosure; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms